isomethyleugenol has been researched along with Giant Cell Tumor of Bone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, M; Fujiwara, T; Ishihara, S; Ito, Y; Iwasaki, T; Kakuda, Y; Kawaguchi, K; Kinoshita, I; Kohashi, K; Matsumoto, Y; Nakashima, Y; Oda, Y; Setsu, N; Susuki, Y; Toda, Y; Yamada, Y; Yamamoto, H; Yamamoto, T; Yoshimoto, M | 1 |
| Li, W; Shi, J; Shi, L; Shi, X; Wen, H | 1 |
| Bovée, JV; Briaire-de Bruijn, I; Cleton-Jansen, AM; Cleven, AH; Höcker, S; Szuhai, K | 1 |
| Abe, K; Aiba, H; Hayashi, K; Higuchi, T; Miwa, S; Murakami, H; Rosario, M; Takeuchi, A; Taniguchi, Y; Tanzawa, Y; Tsuchiya, H; Yamamoto, N | 1 |
4 other study(ies) available for isomethyleugenol and Giant Cell Tumor of Bone
| Article | Year |
|---|---|
Histological and immunohistochemical features and genetic alterations in the malignant progression of giant cell tumor of bone: a possible association with TP53 mutation and loss of H3K27 trimethylation.
Topics: Bone Neoplasms; Giant Cell Tumor of Bone; Histones; Humans; In Situ Hybridization, Fluorescence; Methylation; Mutation; Sarcoma; Tumor Suppressor Protein p53 | 2022 |
Histone H3.3 G34 Mutations Alter Histone H3K36 and H3K27 Methylation In Cis.
Topics: Bone Neoplasms; Brain Neoplasms; Child; Epigenesis, Genetic; Giant Cell Tumor of Bone; Glioblastoma; HeLa Cells; Histones; Humans; Lysine; Methylation; Mutation | 2018 |
Mutation Analysis of H3F3A and H3F3B as a Diagnostic Tool for Giant Cell Tumor of Bone and Chondroblastoma.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Biopsy; Bone Neoplasms; Chondroblastoma; Diagnosis, Differential; DNA Helicases; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Giant Cell Tumor of Bone; Histones; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Male; Methylation; Middle Aged; Mutation; Nuclear Proteins; Phenotype; Predictive Value of Tests; Tissue Array Analysis; X-linked Nuclear Protein; Young Adult | 2015 |
Pathogenesis of Osteosclerotic Change Following Treatment with an Antibody Against RANKL for Giant Cell Tumour of the Bone.
Topics: Adult; Alkaline Phosphatase; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Female; Giant Cell Tumor of Bone; Histones; Humans; Immunohistochemistry; Lysine; Male; Methylation; Microscopy, Fluorescence; Middle Aged; Osteocalcin; Osteogenesis; RANK Ligand | 2017 |